Page last updated: 2024-09-05

ml 23 and Atrophy

ml 23 has been researched along with Atrophy in 1 studies

*Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chantegrel, J; Claustrat, B; Luu-Duc, C; Marsura, A; Masson-Pévet, M; Pévet, P1

Other Studies

1 other study(ies) available for ml 23 and Atrophy

ArticleYear
Failure of N-(2,4-dinitrophenyl)-5-methoxytryptamine (a putative melatonin antagonist) and of N-(3,5-dinitrophenyl)-5-methoxytryptamine to prevent the effects of injections of melatonin in the late afternoon on testicular activity of the golden hamster.
    The Journal of endocrinology, 1989, Volume: 123, Issue:2

    Topics: 5-Methoxytryptamine; Animals; Atrophy; Cold Temperature; Cricetinae; Light; Male; Melatonin; Mesocricetus; Serotonin; Testis

1989
chemdatabank.com